纳指生物科技ETF(513290)
动态评分： 5.56分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2024-12-31 | GILD | 吉利德科学 | 13157.9 | 8.62% |
| 2024-12-31 | AMGN | 安进 | 12151.3 | 7.96% |
| 2024-12-31 | REGN | 再生元制药 | 11733.7 | 7.68% |
| 2024-12-31 | VRTX | 福泰制药 | 11344.6 | 7.43% |
| 2024-12-31 | AZN | 阿斯利康(US ADR) | 5815.24 | 3.81% |
| 2024-12-31 | ALNY | Alnylam Pharmaceuticals Inc | 4626.09 | 3.03% |
| 2024-12-31 | BIIB | 生化基因 | 3396.46 | 2.22% |
| 2024-12-31 | ILMN | Illumina Inc | 3230.35 | 2.12% |
| 2024-12-31 | ARGX | argenx SE ADR | 3022.55 | 1.98% |
| 2024-12-31 | MRNA | Moderna Inc | 2438.85 | 1.6% |
| 2024-12-31 | UTHR | 联合治疗 | 2400.91 | 1.57% |
| 2024-12-31 | VTRS | Viatris Inc | 2265.01 | 1.48% |
| 2024-12-31 | SNY | 赛诺菲 | 2213.48 | 1.45% |
| 2024-12-31 | NBIX | 神经分泌生物科学 | 2106.48 | 1.38% |
| 2024-12-31 | INCY | 因塞特医疗 | 2028.16 | 1.33% |
| 2024-12-31 | SMMT | Summit Therapeutics Inc | 2005.82 | 1.31% |
| 2024-12-31 | BMRN | 拜玛林制药 | 1909.39 | 1.25% |
| 2024-12-31 | INSM | Insmed Inc | 1882.62 | 1.23% |
| 2024-12-31 | SRPT | Sarepta Therapeutics Inc | 1770.28 | 1.16% |
| 2024-12-31 | RPRX | Royalty Pharma plc-A | 1727.55 | 1.13% |
公告&资料